Endothelial cell dysfunction and nitric oxide synthase.
Goligorsky
M S
MS
Division of Nephrology and Hypertension, University Hospital and Medical Center, Stony Brook, New York, USA.
D000368:Aged; D002199:Capillary Permeability / Q000502:physiology; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism; D016228:Endothelial Growth Factors / Q000378:metabolism; D004727:Endothelium / Q000201:enzymology* / Q000648:ultrastructure; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000378:metabolism; D006943:Hyperglycemia / Q000378:metabolism; D020138:Hyperhomocysteinemia / Q000378:metabolism; D017379:Hypertrophy, Left Ventricular / Q000378:metabolism*; D007668:Kidney / Q000098:blood supply / Q000201:enzymology / Q000648:ultrastructure; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D008222:Lymphokines / Q000378:metabolism; D008297:Male; D008855:Microscopy, Electron, Scanning; D008875:Middle Aged; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III